Home › Funds › STEELHEAD PARTNERS LLC › ALNY
STEELHEAD PARTNERS LLC position in ALNY
ALNYLAM PHARMACEUTICALS INC · Health Care
STEELHEAD PARTNERS LLC reported holding 73,080,000 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$79.6M, representing 6.02% of its reported portfolio and ranking #8 among its reported holdings. STEELHEAD PARTNERS LLC has disclosed ALNY holdings in 3 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How STEELHEAD PARTNERS LLC's ALNY position evolved
STEELHEAD PARTNERS LLC first disclosed a stake in ALNY in Q2 2024 at 26,500,000 shares (US$28.6M). The position peaked in Q3 2026 at 73,080,000 shares, worth US$79.6M. Across 3 filings, STEELHEAD PARTNERS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 73,080,000 shares valued at US$79.6M — an increase of 8,080,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 26.50M | $28.57M | New |
| Q2 2026 | 65.00M | $78.16M | New |
| Q3 2026 | 73.08M | $79.57M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALNY and 13F data
ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 30 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$1.36B), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALNY
- T. Rowe Price Investment Management, Inc. 5.64M sh · $1.70B · Q2 2026
- Baillie Gifford & Co 5.49M sh · $1.36B · Q3 2026
- Orbis Allan Gray Ltd 1.99M sh · $598.27M · Q2 2026
- Two Sigma Investments 1.88M sh · $564.71M · Q2 2026
- TWO SIGMA ADVISERS, LP 1.13M sh · $450.36M · Q4 2025
- Deep Track Capital, LP 825.00K sh · $248.35M · Q2 2026
More on STEELHEAD PARTNERS LLC
FAQ
How long has STEELHEAD PARTNERS LLC held ALNY?
STEELHEAD PARTNERS LLC has disclosed ALNY holdings in 3 of the last 10 reported quarters, going back to Q2 2024.
What is STEELHEAD PARTNERS LLC's current position in ALNY?
As of Q3 2026, STEELHEAD PARTNERS LLC holds 73.08M shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $79.57M, representing 6.02% of its reported portfolio and ranking #8.
Has STEELHEAD PARTNERS LLC been buying or selling ALNY?
In the latest 13F filing (Q3 2026), STEELHEAD PARTNERS LLC increased its position in ALNY. The position peaked in Q3 2026 at 73.08M shares.
Which other funds hold ALNY?
Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.